Physiopathology Study of the Microbiota Biodiversity of HIV Seropositive Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

80 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-12-31

Study Completion Date

2016-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The bacterial diversity of HIV patients digestive microbiota seropositive is poorly understood, it remains to be defined.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Microbiota Footprint and Frailty Phenotype in Virologically Suppressed People Living With HIV

NCT05078957

HIV Infections

RECRUITING

Exploratory Study on the Role of the Digestive Microbiota in Adults Living With HIV-1

NCT05724524

HIV

WITHDRAWN

Factors Mediating Gut Microbiota Dysbiosis and Metabolic Disease in HIV Patients.

NCT02258685

HIV Lipodystrophy

COMPLETED

HIV and Changes in the Gut Microbiome After Changes in Antiretroviral Therapy (ART)

NCT06100211

HIV Infections

RECRUITING

Diet / Gut Microbiome Interaction and Influence on Inflammatory Disease in HIV Patients

NCT02610374

HIV

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HIV-1 Infection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

HIV-1 patients

Physiopathology study

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Physiopathology study

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient aged 18 or more.
* Patients with a confirmed diagnosis of HIV infection 1.
* Patient who signed an informed consent form.
* Patient affiliated or beneficiary of a social security system.

Exclusion Criteria

* Patient known to be suffering from inflammatory bowel disease (Crohn's disease or ulcerative colitis).
* Patient HIV-2 or HIV-1/HIV-2 co-infected
* Patient having received immunotherapy
* Patient participating in another research.
* Pregnant women, parturient or lactating person under guardianship, or deprived of liberty by a judicial or administrative decision.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No